Skip to main content
OpenTrials
Completed

NCT Number: NCT00425568

Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR

Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase the "hardness" of a man's erection.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–59 year

Sex eligibility

Male

Study type

Observational

Primary location

Steven Lamm, M.D.

New York, 10028, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Testosterone <350 ng/dL,
  • 21-59 years of age,
  • BMI <30

Exclusion criteria

  • Those with carcinoma of the breast or known or suspected carcinoma of the prostate or with known hypersensitivity to any of the ingredients in AndroGel.
  • Men will be excluded if they have unstable angina, hypertension, diabetes, heart failure, or coronary artery disease.
  • Men will agree to discontinue use of current testosterone replacement, as well as Viagra or any other PDE5 inhibitors for 30 days.

Treatment and study plan

AndroGel (Transdermal Testosterone Gel)

Drug

Sponsors and collaborators

Lead sponsor

Lamm, Steven, M.D.

Indiv

Collaborators

  • Solvay Pharmaceuticals

Registry information

Official study title

Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR)

Important dates

Study start
2005
First posted
Jan 23, 2007
Registry last updated
Aug 8, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.